ALEMS.BR Stock - European Medical Solutions
Unlock GoAI Insights for ALEMS.BR
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Free 14-day trial • No credit card required
Premium members get real-time SMS alerts
Financial Statements
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $45.13M | $40.56M | $37.06M | $38.02M | $358,944 |
| Gross Profit | $14.96M | $13.51M | $13.78M | $13.80M | $358,944 |
| Gross Margin | 33.1% | 33.3% | 37.2% | 36.3% | 100.0% |
| Operating Income | $1.25M | $-135,000 | $-5,292,000 | $29,000 | $-897,000 |
| Net Income | $546,000 | $-709,000 | $-5,577,000 | $-241,000 | $-1,362,000 |
| Net Margin | 1.2% | -1.7% | -15.1% | -0.6% | -379.4% |
| EPS | $0.13 | $-0.18 | $-1.32 | $-3.52 | $-21.90 |
European Medical Solutions engages in the design, development, and manufacturing of medical imaging systems for digital radiology and bone densitometry in Belgium. It offers R/F solutions, including PLATINUM NEO, a smart solution that revolutionizes the R/F workflow, as well as OPTIMA dRF, a robust solution; bone densitometry and body composition analysis equipment; chest and bone rooms, such as floor and ceiling tube stands; ambulatory radiography equipment; retrofit kits; C-ARM mobile operating room solutions; and mammography solutions. The company was formerly known as DMS Imaging SA and changed its name to European Medical Solutions in June 2024. DMS Imaging SA was founded in 1979 and is headquartered in Ixelles, Belgium. European Medical Solutions operates as a subsidiary of Diagnostic Medical Systems S.A.
Visit WebsiteEarnings History & Surprises
ALEMS.BREPS Surprise History
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q2 2026 | Apr 13, 2026 | — | — | — | — |
Q3 2025 | Jul 16, 2025 | — | — | — | — |
Q2 2025 | Apr 16, 2025 | — | $0.04 | — | — |
Q4 2024 | Oct 17, 2024 | — | $0.09 | — | — |
Q1 2024 | Jan 18, 2024 | — | $-0.34 | — | — |
Q2 2023 | Jun 30, 2023 | — | $0.17 | — | — |
Q4 2022 | Dec 31, 2022 | — | $-0.37 | — | — |
Q2 2022 | Jun 30, 2022 | — | $-0.95 | — | — |
Q4 2021 | Dec 31, 2021 | — | $63.27 | — | — |
Q2 2021 | Jun 30, 2021 | — | $-1.62 | — | — |
Q4 2020 | Dec 31, 2020 | — | $-0.71 | — | — |
Q2 2020 | Jun 30, 2020 | — | $-21.12 | — | — |
Q4 2019 | Dec 31, 2019 | — | $-130.40 | — | — |
Q2 2019 | Jun 30, 2019 | — | $-140.80 | — | — |
Q4 2018 | Dec 31, 2018 | — | $-178.65 | — | — |
Q2 2018 | Jun 30, 2018 | — | $-119.68 | — | — |
Q4 2017 | Dec 31, 2017 | — | $-142.67 | — | — |
Q2 2017 | Jun 30, 2017 | — | $-186.56 | — | — |
Q4 2016 | Dec 31, 2016 | — | $-134.40 | — | — |
Q2 2016 | Jun 30, 2016 | — | $-271.04 | — | — |